Free Trial
LON:EKF

EKF Diagnostics (EKF) Share Price, News & Analysis

EKF Diagnostics logo
GBX 26 -1.00 (-3.70%)
As of 11:51 AM Eastern

About EKF Diagnostics Stock (LON:EKF)

Key Stats

Today's Range
26
27
50-Day Range
19.80
27
52-Week Range
18.40
32.90
Volume
82,833 shs
Average Volume
433,616 shs
Market Capitalization
£115.56 million
P/E Ratio
24.20
Dividend Yield
3.85%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

EKF Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

EKF Stock Analysis - Frequently Asked Questions

EKF Diagnostics' stock was trading at GBX 27 at the beginning of 2025. Since then, EKF stock has decreased by 3.7% and is now trading at GBX 26.

EKF Diagnostics Holdings plc (LON:EKF) released its earnings results on Tuesday, March, 25th. The company reported $1.38 earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a trailing twelve-month return on equity of 7.03%.

Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that EKF Diagnostics investors own include ERBA Diagnostics (ERBA), boohoo group (BOO), Lloyds Banking Group (LLOY), 888 (888), Abcam (ABC), ASOS (ASC) and Babcock International Group (BAB).

Company Calendar

Last Earnings
3/25/2025
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:EKF
CIK
N/A
Fax
N/A
Employees
356
Year Founded
N/A

Profitability

Trailing P/E Ratio
24.39
Forward P/E Ratio
11.40
P/E Growth
N/A
Net Income
£4.68 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£49.91 million
Cash Flow
GBX 2.46 per share
Price / Cash Flow
10.64
Book Value
GBX 15.41 per share
Price / Book
1.70

Miscellaneous

Free Float
N/A
Market Cap
£116.50 million
Optionable
Not Optionable
Beta
0.57
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:EKF) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners